Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2026-01-02 @ 1:30 PM
Study NCT ID:
NCT05781750
Status:
TERMINATED
Last Update Posted:
2025-12-05
First Post:
2023-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Sponsor:
Kezar Life Sciences, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KZR-616-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None